Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 5/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.38 |
| ▸ | KIF11 | P52732 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | TYMS | P04818 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 1/20 | 0.32 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 2/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.32 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26233298 | 0.85 | CYP1A2 (0.38) | CYP2A6CYP1A2KIF11ACHELMNA | |
| SCHEMBL20315031 | 0.80 | CYP1A2 (0.36) | CYP2A6CYP1A2LMNATRPA1CHRM1 | |
| SCHEMBL14525500 | 0.76 | NFE2L2 (0.39) | CYP2A6CYP1A2KIF11ACHELMNA | |
| SCHEMBL25763688 | 0.76 | CYP1A2 (0.48) | CYP2A6CYP1A2ACHELMNASLC6A2 | |
| SCHEMBL6366989 | 0.75 | CYP1A2 (0.57) | CYP2A6CYP1A2LMNATDP1TRPA1 | |
| SCHEMBL24897763 | 0.73 | CA3 (0.40) | CYP2A6CYP1A2KIF11ACHETYMS | |
| SCHEMBL19983447 | 0.71 | GAA (0.48) | CYP1A2LMNATYMSDHODHKDM4E | |
| SCHEMBL21788088 | 0.70 | SMN1; SMN2 (0.41) | CYP2A6CYP1A2KIF11ACHELMNA | |
| SCHEMBL7666203 | 0.70 | CYP1A2 (0.52) | CYP2A6CYP1A2KIF11ACHELMNA | |
| SCHEMBL21872045 | 0.69 | CYP1A2 (0.40) | CYP2A6CYP1A2KIF11LMNATYMS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240025934-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-01-25 | — | — | US | disclosed |
| US-20240025934-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-01-25 | — | — | US | disclosed |
| US-11753425-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-12 | — | — | US | disclosed |
| US-11753425-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-12 | — | — | US | disclosed |
| US-20200075870-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240025934-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | SSB, RO60, LIFR | CYP2A6 3466/4885CYP1A2 3956/4885KIF11 2992/4885 |
| US-20200075870-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OSBP | CYP2A6 1209/4885CYP1A2 207/4885KIF11 3585/4885 |
| US-11753425-B2 | Organic electroluminescent materials and devices | SSB, RO60, LIFR | CYP2A6 3466/4885CYP1A2 3956/4885KIF11 2992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.